What is the Org number of NorthX Biologics Holding AB?

NorthX Biologics Holding AB is registered with Bolagsverket / SCB under Org 5593371742.

Who is the CEO of NorthX Biologics Holding AB?

Adriana Jannetje Hoogstraate is Chief Executive Officer of NorthX Biologics Holding AB, in role since 2023.

Thomas Bengt Eldered chairs the board of NorthX Biologics Holding AB, in role since 2022.

ABActive

Actively employed in the business

Name	Role	Member since
Current (2)
AJ Adriana Jannetje Hoogstraate Chief Executive Officer	Chief Executive Officer	2023
RJ Robert Jan Hasslund Chief Auditor	Chief Auditor	2021
Former (1)
TI Ted Ingemar Jakob Fjällman Chief Executive Officer	Chief Executive Officer	2022 – 2022

Non-executive oversight

Name	Role	Member since
Current (7)
IC Ingrid Charlotta Ljungqvist	Board of Directors	2022
TB Thomas Bengt Eldered	Chairman	2022
AF Ashley Friedman	Deputy Board Member	2025
MR Mark Royston Quick	Board of Directors	2024
LR Lars Rickard Backsell	Board of Directors	2022
JC James Charles Gale	Board of Directors	2025
MJ Mia Johanna Phillipson	Board of Directors	2026
Former (14)
HJ Hans Jarl Rutger Arnhult	Deputy Board Member	2021 – 2022
BD Bo Daniel Falk	Deputy Board Member	2021 – 2022
VE Viktor Elias Bergman Gullmark	Deputy Board Member	2021 – 2022
EM Emma Maria Birgitta Wik	Deputy Board Member	2021 – 2022
AM Anna Matilda Sjödin	Deputy Board Member	2021 – 2022
RA Richard Arne Bergström	Board of Directors	2022 – 2022
LA Lars Anders Larsson	Board of Directors	2021 – 2022
CE Carl Erik Mathias Uhlén	Board of Directors	2022 – 2025
ES Emelie Sofia Bergh	Deputy Board Member	2021 – 2022
AC Anna Carolina Maria Bjarnhagen	Deputy Board Member	2021 – 2022
RS Rolf Stefan Janse	Deputy Board Member	2021 – 2022
IH Ida Helena Christina Strigård	Chairman	2022 – 2022
MS Mari Sinikka Kovaniemi Feldt	Deputy Board Member	2021 – 2022
OK Olina Kristina Maria Wåhlstedt	Deputy Board Member	2021 – 2022

As of last annual report

Shareholder	Type	Ownership	Votes	Since
Flerie Invest AB	Company	100%	100%	0001

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.